Microbot Medical reaffirms 2025 achievements, outlines 2026 milestones including Full Market Release in Q2

Microbot Medical Inc.

Received FDA 510(k) clearance for LIBERTY, first single-use remotely operated robotic system for peripheral endovascular procedures.
Emory University Hospital became first adopter of LIBERTY under Limited Market Release; 100% robotic navigation success in ACCESS PVI trial.
Full Market Release of LIBERTY planned for Q2 2026, coinciding with SIR conference.
Targeting 2.5 million annual peripheral endovascular procedures in U.S.; building pipeline for cardiology and neurovascular spaces.
Expanded IP portfolio to 20 patents granted, 52 applications pending; balance sheet bolstered with non-dilutive grant.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-001234
form_type: 8-K
ticker: MBOT
cik: 0000883975
company_name: Microbot Medical Inc.
filed_at: 2026-01-12T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.909710+00:00
generated_at: 2026-05-16T11:00:01.086872+00:00
sec_items: ["8.01", "9.01"]
event_type: other
sentiment: neutral
materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-001234
json_url: https://secwatch.observer/filing/0001493152-26-001234.json
markdown_url: https://secwatch.observer/filing/0001493152-26-001234.md
text_url: https://secwatch.observer/filing/0001493152-26-001234.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226001234/0001493152-26-001234-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226001234/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-001234

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.